Clinical characteristics of the alpha-synuclein mutation (G209A)-associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece
- PMID: 12752402
- DOI: 10.1046/j.1468-1331.2003.00576.x
Clinical characteristics of the alpha-synuclein mutation (G209A)-associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece
Abstract
An Ala53Thr mutation of the alpha-synuclein has been recently identified as a rare cause of familial Parkinson's disease (fPD). In the present study, the clinical characteristics of Parkinson's disease (PD) patients with Ala53Thr alpha-synuclein mutation (alpha-synPD) were compared with fPD patients without any known mutation. An investigator blinded to the results of the genetic analysis examined 15 alpha-synPD patients and 43 consecutive fPD patients. Demographic data, age at onset of the illness, duration of the disease and modality of presentation were collected. Segregation ratios for both sexes in individuals at risk of developing alpha-synPD were estimated. The Unified Parkinson's disease rating scale (UPDRS) was also completed. The 15 alpha-synPD patients were matched for duration of the disease and age at onset with 15 of the 43 fPD patients (MfPD). Comparisons were also made between 14 patients belonging to three multicase families with patterns of inheritance similar to alpha-synPD. The alpha-synPD patients were significantly younger (mean difference 11.8 years) and showed the first sign of the disease earlier in life (mean difference 12.7 years) as compared with the fPD patients. Tremor at onset was present in only one (6.7%) of the alpha -synPD patients compared with 18 (41.9%) of the fPD patients (P = 0.01). At the time of examination rigidity, postural instability, orthostatic hypotension and the overall clinical severity did not differ significantly either between alpha-synPD and fPD or between alpha-synPD and MfPD groups. Nevertheless, some clinically relevant trends concerning the psychiatric symptoms and complications of therapy were recognized. The overall clinical severity and the progression of the disease in patients with alpha-synPD did not differ from that of the fPD patients. The alpha-synPD patients presented the illness at a younger age and also had lower prevalence of tremor when compared with the fPD patients.
Similar articles
-
Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease.J Neurol Neurosurg Psychiatry. 2001 May;70(5):662-5. doi: 10.1136/jnnp.70.5.662. J Neurol Neurosurg Psychiatry. 2001. PMID: 11309462 Free PMC article.
-
The G209A mutation in the alpha-synuclein gene in Brazilian families with Parkinson's disease.Arq Neuropsiquiatr. 2001 Sep;59(3-B):722-4. doi: 10.1590/s0004-282x2001000500013. Arq Neuropsiquiatr. 2001. PMID: 11593272
-
Haploinsufficiency at the alpha-synuclein gene underlies phenotypic severity in familial Parkinson's disease.Brain. 2003 Jan;126(Pt 1):32-42. doi: 10.1093/brain/awg010. Brain. 2003. PMID: 12477695
-
[Molecular biology for familial Parkinson's disease].Nihon Rinsho. 2004 Sep;62(9):1617-22. Nihon Rinsho. 2004. PMID: 15462374 Review. Japanese.
-
Genetics of Parkinson's disease and biochemical studies of implicated gene products.Curr Opin Cell Biol. 2002 Oct;14(5):653-60. doi: 10.1016/s0955-0674(02)00377-0. Curr Opin Cell Biol. 2002. PMID: 12231362 Review.
Cited by
-
Mitochondrial therapy for Parkinson's disease: neuroprotective pharmaconutrition may be disease-modifying.Clin Pharmacol. 2010;2:185-98. doi: 10.2147/CPAA.S12082. Epub 2010 Sep 17. Clin Pharmacol. 2010. PMID: 22291504 Free PMC article.
-
Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset.Eur J Hum Genet. 2010 Mar;18(3):336-41. doi: 10.1038/ejhg.2009.179. Epub 2009 Oct 14. Eur J Hum Genet. 2010. PMID: 19826450 Free PMC article.
-
A population-based study of parkinsonism in an Amish community.Neuroepidemiology. 2009;33(3):225-30. doi: 10.1159/000229776. Epub 2009 Jul 27. Neuroepidemiology. 2009. PMID: 19641327 Free PMC article.
-
Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background.Biomedicines. 2025 Jul 2;13(7):1624. doi: 10.3390/biomedicines13071624. Biomedicines. 2025. PMID: 40722695 Free PMC article. Review.
-
Multiple system atrophy: genetic or epigenetic?Exp Neurobiol. 2014 Dec;23(4):277-91. doi: 10.5607/en.2014.23.4.277. Epub 2014 Dec 12. Exp Neurobiol. 2014. PMID: 25548529 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous